MMP1 is upregulated in patients with HCC and is associated with a poor prognosis.[42] Pharmacological inhibition and gene silencing of TRPA1 downregulates MMP1 production in osteoarthritis,[43] whereas activation of TRPV1 increases the expression of MMP1. This evidence concerns the gene TRPV1 and hepatocellular carcinoma.